Pharma company
The company said researchers found that the level of neutralizing antibodies increased 25-fold in people who'd received a third dose of the vaccine, which it developed with
The research indicates that the initial two doses of the
"Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it's clear from these preliminary data that protection is improved with the third dose of our vaccine,"
"Ensuring as many people as possible are fully vaccinated with the first two-dose series and a booster remains the best course of action to prevent the spread of COVID-19."
The companies said the new research may be critical as the world enters its second winter season of the COVID-19 era.
"Broad vaccination and booster campaigns around the world could help us to better protect people everywhere and to get through the winter season," Dr.
"We continue to work on an adapted vaccine which, we believe, will help to induce a high level of protection against Omicron-induced COVID-19 disease as well as a prolonged protection compared to the current vaccine."
Copyright 2021 United Press International, Inc. (UPI). Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent., source